Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SS1: Pilot Study of Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (MDS)

NCT02452983 is registered in ClinicalTrials.gov with Gustavo Rivero as lead sponsor.

NCT NCT02452983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02452983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SS1: Pilot Study of Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome (MDS)
Lead sponsor
Gustavo Rivero
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2015
Completion date
November 30, 2020
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes